Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Reported Basic Consolidated EPS Of $-5.2884

0

For the period ended 2015-12-31, Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) reported $-5.2884 as the annual basic consolidated EPS. On quarterly basis, $-5.2884 was captured as the basic consolidated EPS reading for the quarter ended 2015-12-31.

EPS from continuing operations

For the annual period ended 2015-12-31 and in line with the basic EPS from continuing operations Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) reported $-5.4022. For the three-month period ended 2015-12-31, quarterly basis EPS from continuing operations stood at $-5.4022.

EPS contribution from parent

Basic EPS received by Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) from its parent company was $-5.2884 for the annual period ended 2015-12-31. For the period ended 2015-12-31, the quarterly basis the basic EPS contribution from the parent company was $-5.2884.

Basic net EPS

Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) reported basic net EPS of $-5.4022 for the annual period ended 2015-12-31. The company’s basic net EPS on a quarterly basis stood at $-5.4022 for the three-month period ended 2015-12-31.

Consolidated diluted EPS

The period ended 2015-12-31 had an annual consolidated diluted EPS reading of $-5.2884. Consolidated diluted EPS for the quarter ended 2015-12-31 was $-5.2884.

b>Basic diluted EPS

For the period ended 2015-12-31 diluted EPS reading from continuing operation on annual basis was $-5.4022. However, $-5.4022 was registered as the Diluted EPS from continuing operations for the quarter ended 2015-12-31.

Net diluted EPS

For the annual period ended 2015-12-31, $-5.4022 was the Net diluted EPS reading. But the quarterly period that ended 2015-12-31, net diluted EPS was $-5.4022.

Diluted EPS from parent

Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) received diluted EPS of $-5.2884 from the parent company which was for the annual period ended 2015-12-31. However, on quarterly basis, $-5.2884 was the diluted EPS contribution from the parent for the quarter ended 2015-12-31. The net basic EPS reading of $-5.4022 was posted by Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) which was representing the annual period ended 2015-12-31. Basic net EPS of $-5.4022 was for the quarter ended 2015-12-31.

For the annual period ended 2015-12-31, Net diluted EPS was $-5.4022 for the annual period ended 2015-12-31. There was also a report by the company of $-5.4022 being the net diluted EPS reading for the quarter ended 2015-12-31.

While the shares for the quarter ended 2015-12-31 were at 3, the period ended 2015-12-31 is 3 being the annual average basic shares outstanding.

For the fiscal year ended is 2015-12-31 while 3 represents the quarter ended 2015-12-31.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 38 times, 1 visits today)